Mini reviewPublished 28 Mar 2023
A Prospective Medication for the Treatment of Illnesses of the Cardiovascular and Neurological Systems is Stachydrine
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In terms of effective medical treatment, cardiovascular disease (CVD), which is the leading cause of death worldwide, presents a significant obstacle. Traditional Chinese herb Leonurus japonicus Houtt is widely used in China to treat obstetrical and gynecological conditions like menstrual disorders, dysmenorrhea, amenorrhea, blood stasis, postpartum bleeding, and blood-related diseases like cardiovascular disease. It has been demonstrated that stachydrine, the primary alkaloid in Leonurus, has a wide range of biological activities, including antioxidant, anti-coagulant, anti-apoptotic, vasodilator, and angiogenic promoter. Also, it has been shown to enjoy remarkable benefits in the avoidance and treatment of CVD through guideline of different illness related flagging pathways and sub-atomic targets. In this exhaustive audit, we analyze the most recent pharmacological impacts and atomic components of Stachydrine in treating cardiovascular and cerebrovascular illnesses. We want to establish a solid scientific foundation for the creation of new CVD drug formulations.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCardiovascular Diseases & Diagnosis
- SubjectCardiology
- BylineArticles whose byline prints “Li Liao”
